From Tau-Targeting Alzheimer’s Drug from AC Immune, Roche Fails in Phase 2:

aalzheimers-disease-tau-proteins-aggregate-to-neurofibrillary-tangles-picture-id1046071676

aalzheimers-disease-tau-proteins-aggregate-to-neurofibrillary-tangles-picture-id1046071676—

Image: iStock/selvanegra
https://www.istockphoto.com/portfolio/selvanegra?assettype=image&mediatype=photography&sort=best

Underwriters and Partners

Xconomy Insight

Sponsored · Webinar
Sept. 15 – Challenges of Implementing Innovation in Drug Discovery & Development
Phenotypic Screening & Profiling to Understand a Compound's Disease Impact
Eurofins Discovery

Sponsored · Whitepaper
Potency Assay Development for Cell and Gene Therapy Products
Create well-controlled, biologically relevant test systems and validate them to support FDA approvals
Absorption Systems

Sponsored · Whitepaper
How Big Is the US Market for Medical Devices & Technologies?
Knowing the volume of procedures and growth trends by site of care can allow you to understand the market demand for your product
IBM Watson

Xconomy on Demand

We offer a number of ways to subscribe for free!